NLS Pharmaceutics Ltd. Quarterly Assets in USD from Q4 2019 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: NLS Pharmaceutics Ltd. quarterly Assets history and growth rate from Q4 2019 to Q2 2024.
NLS Pharmaceutics Ltd. Assets for the quarter ending June 30, 2024 was $1.19M, a 47.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$1.19M	-$1.08M	-47.4%	Jun 30, 2024	6-K	2024-10-18
Q4 2023	$1.85M	-$7.43M	-80.1%	Dec 31, 2023	6-K	2024-10-18
Q2 2023	$2.27M	+$212K	+10.3%	Jun 30, 2023	6-K	2023-12-06
Q4 2022	$9.28M	+$3.51M	+60.9%	Dec 31, 2022	20-F	2024-05-15
Q2 2022	$2.06M	-$6.21M	-75.1%	Jun 30, 2022	6-K	2022-10-11
Q4 2021	$5.76M	+$4.55M	+376%	Dec 31, 2021	20-F	2023-05-05
Q2 2021	$8.27M			Jun 30, 2021	6-K	2021-09-28
Q4 2020	$1.21M	+$515K	+74%	Dec 31, 2020	20-F	2022-03-24
Q4 2019	$696K			Dec 31, 2019	20-F	2021-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.